Croquet Launches Edge Collaboration Platform and Global Developer Infrastructure for Creating Real-Time, Multi-User Web and Mobile Applications
24.8.2021 14:00:00 EEST | Business Wire | Press release
The world’s perception of what real-time collaboration can actually look like is about to change. Croquet Corporation, the technology leader in Edge Collaboration (a new, rapidly-growing sector of Edge Computing) has launched the Croquet Collaboration Platform™ allowing developers worldwide to create multi-user apps with real-time capabilities never before possible.
While Croquet’s exclusive mission is delivering developer tools and infrastructure – including the Croquet Library, APIs and highly useful frameworks – the company has launched a free reference app called PiiX (Photo Instantaneous Interactive Experience) to showcase the technology. PiiX allows anyone, from consumers to sophisticated developers, to test-drive this revolutionary new collaboration technology right now, with no registration required.
Scan a QR code and watch as PiiX, a real-time, collaborative annotation app jumps instantly onto your phone or tablet. Invite others and as you annotate or manipulate the image, the results appear simultaneously in real-time on all participant screens. All users have simultaneous control. Users often describe the experience as “magical”. But it’s the global infrastructure underneath, with frameworks on top, that make everything possible. Click here to try PiiX.
“We believe that all future applications should be collaborative – including apps for productivity, social collaboration, telemedicine, sports, interactive marketing, AR/VR, SaaS, gaming, you name it,” says David A. Smith, Founder & CTO of Croquet. “With this launch, Croquet is delivering all of the tools and infrastructure developers need to easily build mind-blowing, real-time, fully synchronous collaborative apps that make today’s multi-user apps look like anachronisms. We expect that developers will find amazing ways to use this technology that we haven’t even imagined yet.”
Croquet was funded in early 2020 to pursue development and private beta testing of the infrastructure, libraries, tools and reference app launched today. Use cases for the technology are vast and varied across startups, the enterprise, commercial applications, social collaboration, media, marketing, interactive advertising and social games. See more use case detail on the Croquet website.
A Peek Under the Hood
Croquet’s first-of-its-kind Edge Collaboration infrastructure is deployed globally today on every continent (except Antarctica). It provides a super-fast reflector-based network (with latency as low as 10-15ms, depending on location), as well as a unique edge collaboration protocol and synchronization service that enable real-time collaboration at the edge of the network where performance is best. Servers have long stood between users and real-time collaboration. With Edge Collaboration, nothing runs on servers so developers are free to easily create apps for instantaneous shared experiences.
All the “smarts” of the application are on the client side. Each user is operating a shared virtual machine, with everyone’s device guaranteed to run the exact same program at exactly the same time, in exactly the same way. These client-side, bit-identical virtual machines use a replicated computation model that enables ultra-low latency, low bandwidth synchronization and instantaneous interactions.
Applications generate events which are sent to an Edge Reflector, the architectural center of the Croquet infrastructure, which then redistributes it to each session participant’s replicated virtual machine, providing precise synchronization with exceedingly low latency. Reflectors are small pieces of software that sit on the Edge and are spun up or down as needed anywhere in the world to support high performance sessions. Croquet Infrastructure is highly scalable with reflectors running across the globe, all designed to work with existing online and mobile networks, including 5G. Developers can sign up here to receive a free key allowing them to start using Croquet.
“Croquet is the best thing I’ve seen in computing over the last 15 years,” says Alan Kay, an advisor to Croquet since its inception, and Turing Award Winner long considered Father of the Personal Computer. “It solves massive problems associated with building real-time collaborative applications in extremely elegant ways. The Internet has been needing this for many years.”
Other key facts about the Croquet Library, API and frameworks include:
- No back-end code; simple front-end, client-side only. Easy for even novice programmers
- Fast and simple to implement. Changes the entire multi-user app development dynamic so developers can build and deploy multi-user apps in days, not months
- Application state is automatically shared so new users can join a live session instantly
- Abstracts the developer from powerful underlying infrastructure; it just works
- Multiple frameworks available for critical tasks
- Works globally with extremely low latency
- Privacy-focused; every message is encrypted end-to-end. The servers only see encrypted data; so even leaks would do no harm to privacy
- No timing issues or out-of-order events. Croquet uses “replicated computation” to eliminate message “collisions”
- Edge reflectors exist as software and have no application state; they are extraordinarily scalable globally and can function as a self-proliferating network
- View this technical FAQ on the Croquet website
Development of the company’s current technology was led by Smith and co-founders Vanessa Freudenberg, Aran Lunzer, Yoshiki Ohshima and Brian Upton – a team of architects and engineers in Los Angeles, CA.
“This is an amazing team that has built something remarkable,” says John Payne, CEO of Croquet. “The Croquet Platform and Infrastructure will enable a whole new breed of applications that couldn’t exist before while supporting the addition of collaboration features to existing applications around the world in a highly scalable way.”
The market for collaboration technology as a whole is massive. COVID has accelerated demand by 10 years, but so far the technology has lagged. Croquet changes the conversation, enabling a huge leap forward in developing Instantaneous Shared Experiences.
About Croquet
Croquet Corporation – the technology leader in Edge Collaboration, a new, rapidly-growing sector of Edge Computing – operates a global Edge Collaboration Platform and Collaboration Infrastructure that enables developers to quickly and easily create a vast range of multi-user collaboration apps for web and mobile, at virtually limitless scale. Croquet has its spiritual roots in work begun in the 1990’s by Founder & CTO David A. Smith, Alan Kay, David P. Reed and Andreas Raab in the Croquet Project, an open source 2D/3D environment for collaborative work written in Smalltalk. Croquet was formed in 2019 and funded by SIP Global Partners and a group of experienced technology and financial industry veterans. Visit www.croquet.io.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210824005340/en/
Contact information
Media/Analyst Contact: Daniel Kehrer: daniel.kehrer@croquet.io
Partnerships Contact: Stu Kozlowski: stu@croquet.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
